Gene: NEFH
Official Full Name: neurofilament heavy chainprovided by HGNC
Gene Summary: Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and functionally maintain neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the heavy neurofilament protein. This protein is commonly used as a biomarker of neuronal damage and susceptibility to amyotrophic lateral sclerosis (ALS) has been associated with mutations in this gene. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04103 | NEFH Knockout cell line (HeLa) | Human | NEFH | 1:3~1:6 | Negative | Online Inquiry |
KO04104 | NEFH Knockout cell line (HEK293) | Human | NEFH | 1:3~1:6 | Negative | Online Inquiry |
NEFH Gene Knockout Cell Lines represent a sophisticated and indispensable tool for researchers investigating the role of neurofilament heavy chain (NEFH) in neural development, function, and disease pathology. These cell lines have been engineered through precise gene-editing techniques, such as CRISPR/Cas9, to disrupt the NEFH gene, enabling scientists to study the downstream effects of NEFH depletion in both in vitro and in vivo models.
NEFH is a vital component of the neuronal cytoskeleton, playing a key role in maintaining the structural integrity of neurons, promoting their growth, and facilitating intracellular transport. By utilizing NEFH gene knockout cell lines, researchers can elucidate the molecular mechanisms underlying neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease, as well as explore the regulation of neurogenesis and axonal transport. The ability to observe cellular responses, such as changes in signaling pathways, neuroinflammation, and cytoskeletal dynamics, positions these cell lines as powerful tools in translational research.
One of the major advantages of NEFH Gene Knockout Cell Lines lies in their specificity and reproducibility. Unlike traditional models that may exhibit variability due to genetic background or environmental factors, these knockout lines provide a consistent platform for hypothesis testing. This specificity aids in drawing clear conclusions regarding the effects of NEFH loss, thereby expediting the discovery of potential therapeutic targets.
Moreover, NEFH gene knockout cell lines contribute significantly to drug discovery efforts aimed at neuroprotection and neurological recovery. By providing an accurate representation of the effects of gene knockout, these cell lines enable researchers to evaluate the efficacy of novel compounds in restoring neuronal function or mitigating disease progression.
At [Your Company Name], we pride ourselves on our commitment to advancing scientific research through high-quality biological products. Our NEFH Gene Knockout Cell Lines are meticulously validated and backed by extensive expertise in gene editing technology, ensuring that our customers have access to robust and reliable tools for their groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.